155P: PD-L1 Polymorphism Can Predict Clinical Outcomes of Non-Small Cell Lung Cancer Patients Treated With First-Line Paclitaxel–cisplatin Chemotherapy

Journal of Thoracic Oncology - United States
doi 10.1016/s1556-0864(16)30265-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy